Elanco Animal Health (ELAN) News Today

Elanco Animal Health (NYSE:ELAN) Trading Down 3.5%

Stifel Nicolaus reaffirmed a "buy" rating and set a $20.00 price objective on shares of Elanco Animal Health in a research note on Thursday.

Elanco Animal Health Incorporated (NYSE:ELAN - Get Free Report) saw some unusual options trading on Thursday. Stock investors acquired 13,430 call options on the company. This represents an increase of approximately 515% compared to the typical volume of 2,185 call options.

Morgan Stanley lowered shares of Elanco Animal Health from an "overweight" rating to an "equal weight" rating and decreased their target price for the company from $17.00 to $15.00 in a research report on Thursday.

Dimensional Fund Advisors LP trimmed its position in shares of Elanco Animal Health Incorporated (NYSE:ELAN - Free Report) by 8.3% in the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 16,495,009 shares of the com

Sofinnova Investments Inc. lifted its stake in shares of Elanco Animal Health Incorporated (NYSE:ELAN - Free Report) by 12.1% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 2,864,250 shares of the company's stock

Black Creek Investment Management Inc. lowered its position in shares of Elanco Animal Health Incorporated (NYSE:ELAN - Free Report) by 11.1% in the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 17,914,446 shares of the company's

Choreo LLC purchased a new stake in Elanco Animal Health Incorporated (NYSE:ELAN - Free Report) in the 2nd quarter, according to its most recent disclosure with the SEC. The fund purchased 43,942 shares of the company's stock, valued at approximately $620,000. A number of other institutional invest

Jupiter Asset Management Ltd. lifted its stake in shares of Elanco Animal Health Incorporated (NYSE:ELAN - Free Report) by 13.0% during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 343,992 shares of the company's stock after pu

TD Asset Management Inc boosted its holdings in shares of Elanco Animal Health Incorporated (NYSE:ELAN - Free Report) by 13.5% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 379,342 shares of the company's stock after buy

Private Management Group Inc. grew its position in Elanco Animal Health Incorporated (NYSE:ELAN - Free Report) by 25.7% in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 887,203 shares of the company's stock after acquiring an ad

Great Lakes Advisors LLC acquired a new stake in shares of Elanco Animal Health Incorporated (NYSE:ELAN - Free Report) in the second quarter, according to the company in its most recent disclosure with the SEC. The firm acquired 1,111,772 shares of the company's stock, valued at approximately $16,0

Shares of Elanco Animal Health Incorporated (NYSE:ELAN - Get Free Report) have received a consensus recommendation of "Moderate Buy" from the seven brokerages that are covering the firm, Marketbeat.com reports. One research analyst has rated the stock with a sell rating, one has assigned a hold

Van ECK Associates Corp cut its holdings in shares of Elanco Animal Health Incorporated (NYSE:ELAN - Free Report) by 9.3% during the 2nd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 1,052,332 shares of the company's stock after selling 107,47

Elanco Animal Health Incorporated (NYSE:ELAN - Get Free Report) saw a significant decrease in short interest during the month of August. As of August 15th, there was short interest totalling 12,080,000 shares, a decrease of 10.5% from the July 31st total of 13,500,000 shares. Based on an average daily trading volume, of 5,370,000 shares, the days-to-cover ratio is presently 2.2 days.

Panagora Asset Management Inc. decreased its position in shares of Elanco Animal Health Incorporated (NYSE:ELAN - Free Report) by 48.8% during the 2nd quarter, according to the company in its most recent disclosure with the SEC. The fund owned 219,735 shares of the company's stock after selling 209

Elanco Animal Health (NYSE:ELAN) Trading 1.9% Higher After Insider Buying Activity

Elanco Animal Health Incorporated (NYSE:ELAN - Get Free Report) Director Michael J. Harrington acquired 3,500 shares of the firm's stock in a transaction on Thursday, August 22nd. The stock was purchased at an average cost of $14.85 per share, for a total transaction of $51,975.00. Following the completion of the acquisition, the director now owns 81,094 shares in the company, valued at $1,204,245.90. The purchase was disclosed in a filing with the SEC, which is available through this hyperlink.

Lecap Asset Management Ltd. trimmed its holdings in Elanco Animal Health Incorporated (NYSE:ELAN - Free Report) by 63.5% in the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 21,709 shares of the company's stock

Assenagon Asset Management S.A. cut its holdings in Elanco Animal Health Incorporated (NYSE:ELAN - Free Report) by 63.7% in the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 334,383 shares of the company's stock after sell

Friedenthal Financial lowered its stake in Elanco Animal Health Incorporated (NYSE:ELAN - Free Report) by 94.6% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,727 shares of the company's stock